Therapy Areas: Inflammatory Diseases
8 July 2020 - - Swiss RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) and UAE-based rare disease company taiba Middle East have formed a Distribution Agreement for both ONP...
7 July 2020 - - US-based nutraceutical company ChromaDex Corp. (NASDAQ: CDXC) has launched a preclinical study in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), ...
7 July 2020 - Cyxone (publ), a Sweden-based biotech company, has named Dr Maarten Kraan as its new senior scientific advisor for the company's project for Rabeximod in rheumatoid arthritis, it wa...
7 July 2020 - United States-based Dragonfly Therapeutics Inc has expanded its collaboration with Bristol Myers Squibb, a United States-based pharmaceutical company, to discover and produce Dragonfly&#...
6 July 2020 - - US-based Dragonfly Therapeutics, Inc has launched a new research collaboration with Bristol Myers Squibb to discover and develop Dragonfly's novel immunotherapies for multiple scl...
6 July 2020 - - The European Commission has granted conditional marketing authorisation for Veklury (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19, US-based ...
Related Headlines